Innovative Technology Cisbio's proprietary HTRF technology positions it as a leader in fluorescence detection for drug discovery and diagnostics, offering potential for collaboration in advanced assay development and instrumentation integration.

Global Presence With facilities in France, the US, Japan, and China, Cisbio has a broad international footprint, providing opportunities to expand sales efforts and tailor solutions to diverse regional needs.

Market Focus Specializing in in vitro diagnostics and drug discovery for cancer, metabolic, and autoimmune diseases, Cisbio presents a strong foothold in high-growth healthcare sectors receptive to innovative assay and diagnostic solutions.

Growth Potential Revenue estimates between 10M and 25M indicate room for expansion; partnering with key players like PerkinElmer can accelerate growth through access to new markets and resources.

Technology Ecosystem Utilizing advanced tech tools such as Azure, SharePoint, and PowerShell, Cisbio demonstrates an openness to digital transformation, suggesting potential for upselling laboratory automation, data management, and cloud-based solutions.